Format

Send to

Choose Destination
Eur Respir J. 2020 Jan 2;55(1). pii: 1900513. doi: 10.1183/13993003.00513-2019. Print 2020 Jan.

Zoonotic tuberculosis in humans assessed by next-generation sequencing: an 18-month nationwide study in Lebanon.

Author information

1
Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France.
2
Laboratoire Microbiologie Santé et Environnement (LMSE), EDST, FSP, Université Libanaise, Tripoli, Lebanon.
3
Université de Lille, CHU Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins and Faculté de Pharmacie, Lille, France.
4
Genoscreen, Lille, France.
5
National Tuberculosis Program, Ministry of Public Health, Tripoli, Lebanon.
6
Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France philip.supply@ibl.cnrs.fr.

Conflict of interest statement

Conflict of interest: S. El Achkar reports a PhD fellowship from Association AZM and Saadeh, logistical and administrative support from National TB program in Lebanon, International Organization for Migration, TDR/World Health Organization Eastern Mediterranean Region, Hamidi Medical Center in Tripoli, Lebanon, Ecole Doctorale en Sciences et Technologie (Université Libanaise), Centre Hospitalier Universitaire de Lille, logistical support from GenoScreen, during the conduct of the study. Conflict of interest: C. Demanche reports a PhD fellowship (to S. El Achkar) from Association AZM and Saadeh, logistical and administrative support from National TB program in Lebanon, International Organization for Migration, TDR/World Health Organization Eastern Mediterranean Region, Hamidi Medical Center in Tripoli, Lebanon, Ecole Doctorale en Sciences et Technologie (Université Libanaise), Centre Hospitalier Universitaire de Lille, during the conduct of the study. Conflict of interest: M. Osman reports a PhD fellowship (to S. El Achkar) from Association AZM and Saadeh, logistical and administrative support from National TB program in Lebanon, International Organization for Migration, TDR/World Health Organization Eastern Mediterranean Region, Hamidi Medical Center in Tripoli, Lebanon, Ecole Doctorale en Sciences et Technologie (Université Libanaise), Centre Hospitalier Universitaire de Lille, other from Genoscreen, during the conduct of the study. Conflict of interest: R. Rafei reports a PhD fellowship (to S. El Achkar) from Association AZM and Saadeh, logistical and administrative support from National TB program in Lebanon, International Organization for Migration, TDR/World Health Organization Eastern Mediterranean Region, Hamidi Medical Center in Tripoli, Lebanon, Ecole Doctorale en Sciences et Technologie (Université Libanaise), Centre Hospitalier Universitaire de Lille, other from Genoscreen, during the conduct of the study. Conflict of interest: M.B. Ismail reports a PhD fellowship (to S. El Achkar) from Association AZM and Saadeh, other from National TB program in Lebanon, International Organization for Migration, TDR/World Health Organization Eastern Mediterranean Region, Hamidi Medical Center in Tripoli, Lebanon, Ecole Doctorale en Sciences et Technologie (Université Libanaise), Centre Hospitalier Universitaire de Lille, other from Genoscreen, during the conduct of the study. Conflict of interest: C. Gaudin was an employee of Genoscreen, during the conduct of the study. Conflict of interest: S. Duthoy was an employee of Genoscreen, during the conduct of the study. Conflict of interest: F. De Matos was an employee of Genoscreen, during the conduct of the study. Conflict of interest: H. Yaacoub has nothing to disclose. Conflict of interest: C. Pinçon has nothing to disclose. Conflict of interest: M. Hamze has nothing to disclose. Conflict of interest: P. Supply reports a PhD fellowship (to S. El Achkar) from Association AZM and Saadeh, logistical and administrative support from National TB program in Lebanon, International Organization for Migration, TDR/World Health Organization Eastern Mediterranean Region, Hamidi Medical Center in Tripoli, Lebanon, Ecole Doctorale en Sciences et Technologie (Université Libanaise), Centre Hospitalier Universitaire de Lille, and consultancy fees from Genoscreen, during the conduct of the study.

Publication type

Publication type

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center